Squitti et al. (2002) and Brewer et al. (2010b) attribute the dysregulation of copper in the brains of AD patients to an increase in the “labile” or exchangeable pool of copper in peripheral circulation as represented by non-ceruloplasmin copper. This evidence concerns the gene CP and Alzheimer disease.